UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies Summary of changes
Can Urol Assoc J
.
2022 Aug;16(8):243-244.
doi: 10.5489/cuaj.8007.
Authors
Andrea Kokorovic
1
,
Alan I So
2
,
Hosam Serag
2
,
Christopher French
3
,
Robert J Hamilton
4
,
Jason P Izard
5
,
Jasmir G Nayak
6
,
Frédéric Pouliot
7
,
Fred Saad
1
,
Bobby Shayegan
8
,
Armen Aprikian
9
,
Ricardo A Rendon
10
Affiliations
1
Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
2
Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada.
3
Division of Urology, Department of Surgery, Memorial University, St. John's, NL, Canada.
4
Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, ON, Canada.
5
Department of Urology, Queen's University, Kingston, ON, Canada.
6
Section of Urology, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada.
7
CHU de Quebec, Université Laval, Quebec, QC, Canada.
8
Division of Urology, Departments of Surgery and Oncology, McMaster University, Hamilton, ON, Canada.
9
McGill University Health Centre, Montreal, QC, Canada.
10
Department of Urology, Dalhousie, University, Halifax, NS, Canada.
PMID:
35905484
PMCID:
PMC9343159
DOI:
10.5489/cuaj.8007
No abstract available